Charles Rogers
Obstetrics & Gynecology · Mobile, ALNPI 1073619078
Payments from drug & device makers
What this record shows
24 manufacturers reported payments, led by Intuitive Surgical at 58.6% of the total. 2025 is the largest year on record at $1,567, 7.4 times the $212 reported in 2019.
Across 75 payments — averaging $34.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- AbbVie$273
- Pfizer$203
- Astellas Pharma US Inc$100
- Therapeuticsmd, Inc.$49
- Bayer$49
- plus $386 from 18 others
Across 252 payments — averaging $7198.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.4M
- GSK$411K
What the payments were for
- Food & beverage$1,04641%
- Education$1,51459%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1 | $1,500 |
| AbbVie | 18 | $273 |
| Pfizer | 16 | $203 |
| Astellas Pharma US Inc | 7 | $100 |
| Therapeuticsmd, Inc. | 4 | $49 |
| Bayer | 3 | $49 |
| Mylan Pharmaceuticals Inc. | 3 | $42 |
| Hologic Sales And Service, LLC | 3 | $42 |
| Baxter Healthcare | 2 | $36 |
| Mayne Pharma Commercial LLC | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Myovant Sciences Inc. | 2 | $26 |
| Coloplast | 1 | $21 |
| Medtronic | 1 | $18 |
| Radius Health, Inc. | 1 | $18 |
| Avion Pharmaceuticals | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $15 |
| Amgen | 1 | $14 |
| Davol Inc. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $13 |
| Agile Therapeutics, Inc. | 1 | $12 |
| Coopersurgical, Inc. | 1 | $12 |
| Novo Nordisk | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,500
How this compares
$2,560 in reported general payments places this provider in the 65th percentile of 537 obstetrics & gynecology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 40 | $19,317 |
| MyfembreeRelugolix/Estradiol/Norethindr | 11 | $12,083 |
| Estradiol | 76 | $1,768 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $100 | $19,31740 claims |
| Sumitomo Pharma America, Inc.Myfembree | $30 | $12,08311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 537 obstetrics & gynecology providers in Alabama.
Other obstetrics & gynecology in Mobile
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Melinda FrameMobile$16K
- Phillip MadoniaMobile$14K
- Quin BixlerMobile$12K
- Amy McCoyMobile$10K
- Jessica JonesMobile$9K
- Margaret KruegerMobile$7K
- Theodore CatranisMobile$7K
- Lauren LambrechtMobile$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.